Related Experiment Video
Updated: Jan 12, 2026
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Validation of the Bronchiectasis Health Questionnaire in Bronchiectasis and Estimation of the Meaningful Score
Pratibha Jha1, Surinder S Birring2, Inderpaul S Sehgal1
1Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background:
The Bronchiectasis Health Questionnaire (BHQ) is a validated tool for assessing health-related quality of life in bronchiectasis. Its psychometric performance and meaningful score difference (MSD) have not been evaluated in allergic bronchopulmonary aspergillosis (ABPA).
Objective:
To evaluate the psychometric properties of the BHQ in bronchiectasis and estimate the MSD in subjects with ABPA.
Methods:
Thirty subjects with bronchiectasis (cohort 1, 83% ABPA) completed the BHQ and Saint George's Respiratory Questionnaire at baseline and after 14 days to assess acceptability, validity, internal consistency, and test-retest reliability. For MSD estimation, 72 treatment-naive subjects with ABPA (cohort 2) were assessed before and 2 months after oral prednisolone therapy. Clinical measures included BHQ scores, modified Medical Research Council grade, visual analogue scale for dyspnea, spirometry, total IgE levels, chest radiographs, and subjective global assessment. Only anchors with correlation greater than or equal to 0.30 with BHQ change were used for MSD estimation through linear regression, receiver-operating characteristic-curve analysis, and t test, supported by distribution-based methods.
Results:
The BHQ demonstrated acceptability, strong correlation with Saint George's Respiratory Questionnaire (r = -0.80), good internal consistency (Cronbach α = 0.81), and test-retest reliability (intraclass correlation coefficient = 0.81). Item analysis showed 9 of 10 items with adequate item-total correlations (r = 0.43-0.80). Only modified Medical Research Council and visual analogue scale correlations met anchor thresholds. The BHQ scores improved significantly (mean, 57 to 72; P < .001) after treatment. MSD estimates across anchor-based methods ranged from 7.2 to 14.5 points; triangulation yielded an estimate of 10 points.
Conclusions:
The BHQ showed acceptable preliminary psychometric properties in predominantly ABPA-associated bronchiectasis. The MSD estimate for patients with ABPA is 10 points, though comprehensive multicenter validation is needed to confirm these findings.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:28Physical Assessment of the Respiratory Tract I: Health History
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
01:23Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:26Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to...
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...